AUD 0.34
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.25 Million AUD | 95.52% |
2022 | -744.2 Thousand AUD | 65.12% |
2021 | -3 Million AUD | -48.57% |
2020 | -1.29 Million AUD | 72.46% |
2019 | -4.31 Million AUD | -685.85% |
2018 | -4.36 Million AUD | -1.94% |
2017 | -389.08 Thousand AUD | 83.21% |
2016 | -4.45 Million AUD | -229.53% |
2015 | -1.06 Million AUD | -624.63% |
2014 | -144.98 Thousand AUD | 23.8% |
2013 | -190.26 Thousand AUD | 61.38% |
2012 | -479.6 Thousand AUD | -168.29% |
2011 | 721.34 Thousand AUD | 309.36% |
2010 | 230.56 Thousand AUD | -104.3% |
2009 | -21.59 Million AUD | 1372.22% |
2008 | -1.22 Million AUD | 93.45% |
2007 | -21.4 Million AUD | 26.4% |
2006 | -13.01 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -481.93 Thousand AUD | 0.0% |
2023 Q4 | -264.18 Thousand AUD | 0.0% |
2023 Q2 | 234.41 Thousand AUD | 0.0% |
2023 FY | - AUD | 95.52% |
2022 Q4 | -97.92 Thousand AUD | 0.0% |
2022 Q2 | -566.54 Thousand AUD | 0.0% |
2022 FY | - AUD | 65.12% |
2021 Q4 | -626.02 Thousand AUD | 0.0% |
2021 FY | - AUD | -48.57% |
2021 Q2 | -2.11 Million AUD | 0.0% |
2020 FY | - AUD | 72.46% |
2020 Q2 | -1.3 Million AUD | 0.0% |
2020 Q4 | 21.2 Thousand AUD | 0.0% |
2019 FY | - AUD | -685.85% |
2019 Q2 | -1.61 Million AUD | 0.0% |
2019 Q4 | -2.76 Million AUD | 0.0% |
2018 Q2 | 102.06 Thousand AUD | 0.0% |
2018 Q4 | -694.52 Thousand AUD | 0.0% |
2018 FY | - AUD | -1.94% |
2017 Q2 | 184.19 Thousand AUD | 827.27% |
2017 FY | - AUD | 83.21% |
2017 Q4 | -573.27 Thousand AUD | 0.0% |
2017 Q1 | 19.86 Thousand AUD | 0.0% |
2016 FY | - AUD | -229.53% |
2016 Q1 | -1.11 Million AUD | 0.0% |
2016 Q2 | -1.11 Million AUD | 0.0% |
2016 Q4 | 19.86 Thousand AUD | 0.0% |
2015 Q1 | -710.72 Thousand AUD | 0.0% |
2015 Q2 | -710.72 Thousand AUD | 0.0% |
2015 FY | - AUD | -624.63% |
2015 Q4 | -1.11 Million AUD | -57.24% |
2015 Q3 | -710.72 Thousand AUD | 0.0% |
2014 Q1 | -30.47 Thousand AUD | 0.0% |
2014 Q3 | -30.47 Thousand AUD | 0.0% |
2014 Q4 | -710.72 Thousand AUD | -2232.05% |
2014 FY | - AUD | 23.8% |
2014 Q2 | -30.47 Thousand AUD | 0.0% |
2013 Q2 | -47.56 Thousand AUD | 0.0% |
2013 Q1 | -47.56 Thousand AUD | 0.0% |
2013 Q4 | -30.47 Thousand AUD | 35.93% |
2013 FY | - AUD | 61.38% |
2013 Q3 | -47.56 Thousand AUD | 0.0% |
2012 Q1 | -119.9 Thousand AUD | 0.0% |
2012 Q2 | -119.9 Thousand AUD | 0.0% |
2012 FY | - AUD | -168.29% |
2012 Q4 | -47.56 Thousand AUD | 60.33% |
2012 Q3 | -119.9 Thousand AUD | 0.0% |
2011 FY | - AUD | 309.36% |
2011 Q4 | -119.9 Thousand AUD | -169.38% |
2011 Q3 | 172.82 Thousand AUD | 0.0% |
2011 Q2 | 172.82 Thousand AUD | 0.0% |
2011 Q1 | 172.82 Thousand AUD | 0.0% |
2010 Q4 | 172.82 Thousand AUD | 300.63% |
2010 Q3 | -86.13 Thousand AUD | 0.0% |
2010 Q2 | -86.13 Thousand AUD | 0.0% |
2010 FY | - AUD | -104.3% |
2010 Q1 | -86.13 Thousand AUD | 0.0% |
2009 Q2 | -6.2 Million AUD | 0.0% |
2009 Q3 | -6.2 Million AUD | 0.0% |
2009 Q1 | -6.2 Million AUD | 0.0% |
2009 Q4 | -86.13 Thousand AUD | 98.61% |
2009 FY | - AUD | 1372.22% |
2008 FY | - AUD | 93.45% |
2008 Q1 | -382 Thousand AUD | 0.0% |
2008 Q2 | -382 Thousand AUD | 0.0% |
2008 Q4 | -6.2 Million AUD | -1523.08% |
2008 Q3 | -382 Thousand AUD | 0.0% |
2007 Q4 | -382 Thousand AUD | 94.74% |
2007 Q1 | -7.26 Million AUD | 0.0% |
2007 FY | - AUD | 26.4% |
2007 Q3 | -7.26 Million AUD | 0.0% |
2007 Q2 | -7.26 Million AUD | 0.0% |
2006 Q4 | -7.26 Million AUD | -108.72% |
2006 Q1 | -3.48 Million AUD | 0.0% |
2006 Q3 | -3.48 Million AUD | 0.0% |
2006 Q2 | -3.48 Million AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2005 Q4 | -3.48 Million AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alcidion Group Limited | -4.49 Million AUD | 72.026% |
Artrya Limited | -13.95 Million AUD | 90.987% |
Beamtree Holdings Limited | -331 Thousand AUD | -279.976% |
Cogstate Limited | 9.89 Million AUD | 112.715% |
Careteq Limited | -826.61 Thousand AUD | -52.153% |
Doctor Care Anywhere Group PLC | -8.35 Million AUD | 84.945% |
Emyria Limited | -13.03 Million AUD | 90.351% |
Global Health Limited | -1.76 Million AUD | 28.772% |
HITIQ Limited | -2.54 Million AUD | 50.534% |
Intelicare Holdings Limited | -3.02 Million AUD | 58.361% |
Mach7 Technologies Limited | -2.44 Million AUD | 48.497% |
MedAdvisor Limited | 7.04 Million AUD | 117.844% |
Oakridge International Limited | -630.05 Thousand AUD | -99.621% |
Opyl Limited | -3.2 Million AUD | 60.809% |
PainChek Limited | -9.48 Million AUD | 86.745% |
Pro Medicus Limited | 120.76 Million AUD | 101.041% |
Resonance Health Limited | -457 Thousand AUD | -175.208% |
Singular Health Group Ltd | -2.88 Million AUD | 56.407% |
Total Brain Limited | -5.49 Million AUD | 77.095% |